Header cover image

Hong Kong (HSI) Pharma Industry Analysis

UpdatedMay 27, 2025
DataAggregated Company Financials
Companies40
  • 7D5.9%
  • 3M23.2%
  • 1Y21.2%
  • YTDn/a

The Pharma industry is up 5.9% in the last week, with Hansoh Pharmaceutical Group up 8.9%. This takes the industry's 12 month performance to a gain of 21%. Earnings are forecast to grow by 11% annually.

Industry Valuation and Performance

Has the Hong Kong Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 28 May 2025HK$556.4bHK$477.6bHK$28.8b10.8x19.3x1.2x
Fri, 25 Apr 2025HK$511.2bHK$467.0bHK$28.6b10.4x17.9x1.1x
Sun, 23 Mar 2025HK$470.9bHK$466.4bHK$31.8b9x14.8x1x
Tue, 18 Feb 2025HK$432.7bHK$463.0bHK$31.9b8.6x13.6x0.9x
Thu, 16 Jan 2025HK$399.8bHK$459.3bHK$31.7b8x12.6x0.9x
Sat, 14 Dec 2024HK$440.1bHK$462.0bHK$31.9b8.3x13.8x1x
Mon, 11 Nov 2024HK$445.9bHK$467.8bHK$32.4b8.5x13.7x1x
Wed, 09 Oct 2024HK$517.7bHK$475.5bHK$33.0b9.3x15.7x1.1x
Fri, 06 Sep 2024HK$439.0bHK$473.9bHK$32.9b7.9x13.3x0.9x
Sun, 04 Aug 2024HK$419.0bHK$464.3bHK$32.9b7.4x12.7x0.9x
Tue, 02 Jul 2024HK$438.9bHK$461.4bHK$33.7b8.2x13x1x
Thu, 30 May 2024HK$460.1bHK$463.6bHK$33.9b8.4x13.6x1x
Sat, 27 Apr 2024HK$458.9bHK$463.7bHK$33.8b7.5x13.6x1x
Mon, 25 Mar 2024HK$460.5bHK$469.8bHK$32.8b7.8x14.1x1x
Wed, 21 Feb 2024HK$434.0bHK$470.8bHK$33.6b7.5x12.9x0.9x
Fri, 19 Jan 2024HK$433.0bHK$471.4bHK$33.6b7.1x12.9x0.9x
Sun, 17 Dec 2023HK$489.7bHK$472.9bHK$33.8b8x14.5x1x
Tue, 14 Nov 2023HK$491.5bHK$469.1bHK$31.9b7x15.4x1x
Thu, 12 Oct 2023HK$437.8bHK$469.2bHK$31.5b7x13.9x0.9x
Sat, 09 Sep 2023HK$421.1bHK$468.7bHK$31.5b6.8x13.4x0.9x
Mon, 07 Aug 2023HK$471.7bHK$446.7bHK$27.9b9x16.9x1.1x
Wed, 05 Jul 2023HK$507.6bHK$446.1bHK$27.8b9.8x18.3x1.1x
Fri, 02 Jun 2023HK$503.3bHK$448.5bHK$27.9b8.5x18x1.1x
Sun, 30 Apr 2023HK$570.4bHK$453.4bHK$28.5b8.9x20x1.3x
Tue, 28 Mar 2023HK$546.4bHK$444.2bHK$34.0b9.1x16.1x1.2x
Thu, 23 Feb 2023HK$606.0bHK$444.8bHK$35.2b11x17.2x1.4x
Sat, 21 Jan 2023HK$636.0bHK$447.4bHK$35.6b10.7x17.9x1.4x
Mon, 19 Dec 2022HK$617.3bHK$441.6bHK$34.7b10.6x17.8x1.4x
Wed, 16 Nov 2022HK$621.4bHK$439.0bHK$34.3b9.4x18.1x1.4x
Fri, 14 Oct 2022HK$512.8bHK$514.0bHK$39.0b7.8x13.1x1x
Sun, 11 Sep 2022HK$549.4bHK$520.9bHK$40.9b9.7x13.4x1.1x
Tue, 09 Aug 2022HK$593.4bHK$512.4bHK$51.8b8x11.4x1.2x
Thu, 07 Jul 2022HK$652.3bHK$514.0bHK$52.1b9.4x12.5x1.3x
Sat, 04 Jun 2022HK$565.5bHK$515.9bHK$52.1b8.8x10.8x1.1x
Price to Earnings Ratio

10.8x


Total Market Cap: HK$565.5bTotal Earnings: HK$52.1bTotal Revenue: HK$515.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Pharma Industry Price to Earnings3Y Average 14.8x202320242025
Current Industry PE
  • Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 19.3x which is higher than its 3-year average PE of 14.8x.
  • The industry is trading close to its 3-year average PS ratio of 1.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 18% per year over the last three years,
  • Revenues have also declined 2.5% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Comparison

How does Hong Kong Pharma compare with similar industries?

HK Market0.81%
Healthcare3.43%
Pharma5.87%
Pharma5.87%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
3692 Hansoh Pharmaceutical GroupHK$26.556.8%
+HK$10.1b
59.7%PE33.1x
1093 CSPC Pharmaceutical GroupHK$6.909.5%
+HK$6.9b
-1.8%PE16.7x
867 China Medical System HoldingsHK$10.3418.0%
+HK$3.8b
45.0%PE14.2x
2096 Simcere Pharmaceutical GroupHK$11.0612.6%
+HK$3.1b
91.0%PE34.3x
512 Grand Pharmaceutical GroupHK$8.967.4%
+HK$2.2b
82.9%PE12.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

1177

HK$4.25

Sino Biopharmaceutical

7D

1.7%

1Y

47.6%

512

HK$8.96

Grand Pharmaceutical Group

7D

7.4%

1Y

82.9%

2348

HK$1.17

Dawnrays Pharmaceutical (Holdings)

7D

-0.8%

1Y

-0.8%

867

HK$10.34

China Medical System Holdings

7D

18.0%

1Y

45.0%

719

HK$5.94

Shandong Xinhua Pharmaceutical

7D

-1.2%

1Y

4.8%

3737

HK$0.85

Zhongzhi Pharmaceutical Holdings

7D

-8.6%

1Y

-19.8%

455

HK$0.15

Tianda Pharmaceuticals

7D

-10.7%

1Y

-40.0%

575

HK$1.03

Regent Pacific Group

7D

-14.2%

1Y

60.9%

2566

HK$6.06

Hangzhou Jiuyuan Genetic Biopharmaceutical

7D

-6.0%

1Y

n/a